Use of dipeptidyl peptidase IV inhibitors

Details for Australian Patent Application No. 2004290897 (hide)

Owner Novartis AG

Inventors Hughes, Thomas Edward; Pratley, Richard; Foley, James E.

Agent Davies Collison Cave

Pub. Number AU-B-2004290897

PCT Pub. Number WO2005/049022

Priority 60/547,191 24.02.04 US; 60/520,562 17.11.03 US; 60/547,192 24.02.04 US; 60/520,563 17.11.03 US

Filing date 16 November 2004

Wipo publication date 2 June 2005

Acceptance publication date 26 February 2009

International Classifications

A61K 31/00 (2006.01)

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 31/403 (2006.01) - condensed with carbocyclic rings, e.g. carbazole

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/4439 (2006.01)

A61K 31/472 (2006.01) - Non-condensed isoquinolines, e.g. papaverine

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

Event Publications

1 June 2006 PCT application entered the National Phase

  PCT publication WO2005/049022 Priority application(s): WO2005/049022

26 February 2009 Application Accepted

  Published as AU-B-2004290897

25 June 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004290899-Immunoglobulin preparations having increased stability

2004290896-Combination of a DPP IV inhibitor and an antiobesity or appetite regulating agent